333 related articles for article (PubMed ID: 1635125)
1. The change of urinary 11-dehydro-thromboxane B2 and 2,3-dinor-6-keto-prostaglandin F1 alpha in arteriogenic impotence.
Lin JS; Lui SM; Chen CM; Chang WC
J Urol; 1992 Aug; 148(2 Pt 1):311-3. PubMed ID: 1635125
[TBL] [Abstract][Full Text] [Related]
2. The change of penile blood thromboxane B2 and prostacyclin after intracavernous injection of vasoactive drugs for the treatment of arteriogenic impotence.
Lin JS; Chang WC; Lui SM
Proc Natl Sci Counc Repub China B; 1994 Jan; 18(1):12-6. PubMed ID: 8029369
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous measurements of prostacyclin and thromboxane metabolites during the menstrual cycle.
Presser SC; Stanczyk FZ; Lobo RA
Am J Obstet Gynecol; 1991 Sep; 165(3):647-51. PubMed ID: 1892191
[TBL] [Abstract][Full Text] [Related]
4. Urinary excretion of prostacyclin and thromboxane metabolites in threatened preterm labor: effect of indomethacin and nylidrin.
Kurki T; Viinikka L; Ylikorkala O
Am J Obstet Gynecol; 1992 Jan; 166(1 Pt 1):150-4. PubMed ID: 1733190
[TBL] [Abstract][Full Text] [Related]
5. Formation of prostacyclin and thromboxane in man as measured by the main urinary metabolites.
Fischer S; Bernutz C; Meier H; Weber PC
Biochim Biophys Acta; 1986 Apr; 876(2):194-9. PubMed ID: 3754157
[TBL] [Abstract][Full Text] [Related]
6. Prostacyclin-to-thromboxane A2 ratio in arteriogenic impotence.
Kim SC; Choi IG; Oh CH; Cha YJ
J Urol; 1990 Dec; 144(6):1373-5. PubMed ID: 2231931
[TBL] [Abstract][Full Text] [Related]
7. Urinary excretion of thromboxane and prostacyclin metabolites during chronic low-dose aspirin: evidence for an extrarenal origin of urinary thromboxane B2 and 6-keto-prostaglandin F1 alpha in healthy subjects.
Chiabrando C; Rivoltella L; Martelli L; Valzacchi S; Fanelli R
Biochim Biophys Acta; 1992 Feb; 1133(3):247-54. PubMed ID: 1737057
[TBL] [Abstract][Full Text] [Related]
8. Reference intervals and developmental changes in urinary prostanoid excretion in healthy newborns, infants and children.
Leonhardt A; Busch C; Schweer H; Seyberth HW
Acta Paediatr; 1992 Mar; 81(3):191-6. PubMed ID: 1511190
[TBL] [Abstract][Full Text] [Related]
9. Urinary excretion of degradation products of prostacyclin and thromboxane is increased in patients with gestational choriocarcinoma.
Aitokallio-Tallberg AM; Jung JK; Kim SJ; Viinikka LU; Ylikorkala RO
Cancer Res; 1991 Aug; 51(16):4146-8. PubMed ID: 1868436
[TBL] [Abstract][Full Text] [Related]
10. Monitoring of the thromboxane A2/prostacyclin ratio in the urine of patients with retinal vascular occlusion through the low-dose-aspirin therapy using the gas chromatography/selected ion monitoring method.
Mizugaki M; Hishinuma T; Matsumura E; Murai Y; Yamazaki T; Yamanobe S; Tamai M
Prostaglandins Other Lipid Mediat; 1999 Nov; 58(5-6):253-62. PubMed ID: 10593167
[TBL] [Abstract][Full Text] [Related]
11. Quantitative profiling of 6-ketoprostaglandin F1 alpha, 2,3-dinor-6-ketoprostaglandin F1 alpha, thromboxane B2 and 2,3-dinor-thromboxane B2 in human and rat urine by immunoaffinity extraction with gas chromatography-mass spectrometry.
Chiabrando C; Pinciroli V; Campoleoni A; Benigni A; Piccinelli A; Fanelli R
J Chromatogr; 1989 Oct; 495():1-11. PubMed ID: 2613794
[TBL] [Abstract][Full Text] [Related]
12. Chronic effects of oral prostacyclin analogue on thromboxane A2 and prostacyclin metabolites in pulmonary hypertension.
Ichida F; Uese K; Hamamichi Y; Hashimoto I; Tsubata S; Fukahara K; Murakami A; Miyawaki T
Acta Paediatr Jpn; 1998 Feb; 40(1):14-9. PubMed ID: 9583194
[TBL] [Abstract][Full Text] [Related]
13. Effect of the infusion of OKY-046, a thromboxane A2 synthase inhibitor, on urinary metabolites of prostacyclin and thromboxane A2 in healthy human subjects.
Morio H; Hirai A; Terano T; Tamura Y; Yoshida S
Thromb Haemost; 1993 Mar; 69(3):276-81. PubMed ID: 8470052
[TBL] [Abstract][Full Text] [Related]
14. An imbalance between the excretion of thromboxane and prostacyclin metabolites in women after the menopause.
Jendryczko A; Tomala J
Zentralbl Gynakol; 1993; 115(4):163-6. PubMed ID: 8503234
[TBL] [Abstract][Full Text] [Related]
15. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension.
Christman BW; McPherson CD; Newman JH; King GA; Bernard GR; Groves BM; Loyd JE
N Engl J Med; 1992 Jul; 327(2):70-5. PubMed ID: 1603138
[TBL] [Abstract][Full Text] [Related]
16. Decreased systemic formation of prostaglandin E and prostacyclin, and unchanged thromboxane formation, in alcoholics during withdrawal as estimated from metabolites in urine.
Förstermann U; Feuerstein TJ
Clin Sci (Lond); 1987 Sep; 73(3):277-83. PubMed ID: 3308287
[TBL] [Abstract][Full Text] [Related]
17. Do prostacyclin and thromboxane contribute to the "protective effect" of pregnancies with chronic hypertension? A preliminary prospective longitudinal study.
Moutquin JM; Lindsay C; Arial N; De Grandpré P; C-Gaudreault R; Forest JC; Massé J
Am J Obstet Gynecol; 1997 Dec; 177(6):1483-90. PubMed ID: 9423755
[TBL] [Abstract][Full Text] [Related]
18. Prostacyclin and thromboxane in pregnant and nonpregnant women in response to exercise.
Rauramo I; Ilmonen S; Viinikka L; Ylikorkala O
Obstet Gynecol; 1995 Jun; 85(6):1027-30. PubMed ID: 7770249
[TBL] [Abstract][Full Text] [Related]
19. Effects of low-to-high doses of aspirin on platelet aggregability and metabolites of thromboxane A2 and prostacyclin.
Tohgi H; Konno S; Tamura K; Kimura B; Kawano K
Stroke; 1992 Oct; 23(10):1400-3. PubMed ID: 1412574
[TBL] [Abstract][Full Text] [Related]
20. Desogestrel- and levonorgestrel-containing oral contraceptives have different effects on urinary excretion of prostacyclin metabolites and serum high density lipoproteins.
Ylikorkala O; Kuusi T; Tikkanen MJ; Viinikka L
J Clin Endocrinol Metab; 1987 Dec; 65(6):1238-42. PubMed ID: 2960690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
